Market Executive Summary

Global Pharmaceutical Grade CBD Oil market size was US$ 301 million in 2022 and is forecast to a readjusted size of US$ 1416.2 million by 2029 with a CAGR of 28.0% during the forecast period 2023-2029.

The global key manufacturers of Pharmaceutical Grade CBD Oil include Kazmira, Charlotte's Web, GL Brands, Inc., Green Road, Medical Marijuana, Inc., Folium Biosciences, HempLife Today, Cannavest and PHARM-CBD, LLC, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Pharmaceutical Grade CBD Oil, the top five companies hold a share nearly %.

In terms of sales (consumption) side, this report focuses on the sales of Pharmaceutical Grade CBD Oil by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2029.

The global Pharmaceutical Grade CBD Oil market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Pharmaceutical Grade CBD Oil market. These figures have been provided in terms of both revenue and sales for the period 2018-2029. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.

By Company

    Kazmira

    Charlotte's Web

    GL Brands, Inc.

    Green Road

    Medical Marijuana, Inc.

    Folium Biosciences

    HempLife Today

    Cannavest

    PHARM-CBD, LLC

    ENDOCA

    CBD American Shaman

    NuLeaf Naturals

    K.I.N.D. Concentrates

    Canopy Growth Corporation

    Aphria

    Emblem Cannabis Oils

    Whistler

    The Lab

    Absolute Terps

By Type

    Full Spectrum CBD Oil

    Broad Spectrum CBD Oil

By Application

    Anxiety

    Fibromyalgia

    Diabetes

    Others

Sales by Region

    North America

        U.S.

        Canada

    China

    APAC (excluding China)

        Japan

        South Korea

        China Taiwan

       Southeast Asia

    Europe

        Germany

        France

        U.K.

        Italy

        Russia

    Middle East, Africa, Latin America

        Brazil

        Mexico

        Turkey

        Israel

        GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Pharmaceutical Grade CBD Oil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.

Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.

Chapter 8: China by company, by type and by application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Grade CBD Oil sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.